GILD Stock Pops on COVID-19 Treatment Buzz

Gilead's remdesivir was lauded by President Trump last month as a promising COVID-19 treatment

Digital Content Manager
Apr 6, 2020 at 10:18 AM
facebook X logo linkedin

Gilead Sciences, Inc. (NASDAQ:GILD) is up 1% to trade at $79 this morning after the drugmaker said it plans on ramping up production on its experimental coronavirus treatment remdesivir, to 1 million treatment courses by the end of the year. Currently 1.5 million doses of the drug, or 140,000 treatment courses are available.

GILD has been outperforming the broad market for months now. U.S. President Donald Trump's comments last month touting Gilead's remdesivir treatment has undoubtedly helped put wind at the equity's back. Meanwhile, the stock's 60-day moving average has provided technical support on the charts. And while the $80 region, which is home to GILD's two-year closing high, has acted as a ceiling of late, GILD boasts a 20.4% year-to-date gain coming into today. 

Analysts remain split on the biotech name, with 11 calling it a "buy" or better, and 10 saying "hold" or worse. The consensus 12-month price target of $74.79 sits slightly below current levels. 

Analysts, on the other hand, have rarely been more bullish. This is per GILD's 50-day call/put volume ratio of 7.01 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which sits higher than 90% of all other readings from the past year. 


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI